The role of computed tomography in the selection of breast cancer treatment

被引：20

作者：

Akashi-Tanaka S. ^{[1
]}

Fukutomi T. ^{[1
]}

Sate N. ^{[2
]}

Miyakawa K. ^{[2
]}

机构：

[1] Division of Breast Surgey, Chuo-ku, Tokyo 104-0045

[2] Department of Diagnostic Radiology, National Division of Breast Surgey

来源：

Breast Cancer | 2003年 / 10卷 / 3期

关键词：

Axillary lymph node; Breast cancer; Breast conserving Treatment; CT scan; Neoadjuvant chemotherapy;

D O I：

10.1007/BF02966718

中图分类号：

学科分类号：

摘要：

Contrast-enhanced computed tomography (CE-CT) is one of the most sensitive imaging modalities. CE-CT plays a role in the following: (1) to determine the extent of breast cancer to select the appropriate breast conserving treatment (BCT). The sensitivity and specificity for the detection of extensive intraductal component (EIC) by CE-CT were 82-88% and 75-89%, respectively. The pathological extent of tumors significantly correlated with the extension revealed by CE-CT; (2) to determine the extent of resection following neoadjuvant chemotherapy, which is difficult to assess by other modalities; (3) to diagnose axillary lymph node metastasis. The sensitivity and specificity are 79-90% and 70-89%, respectively; (4) to identify occult breast cancer with axillary metastasis and to diagnose local recurrence after BCT.

引用

页码：198 / 203

页数：5

共 33 条

[1]

Muramatsu Y., Akiyama N., Hanai K., Medical exposure in lung cancer screening by helical computed tomography, Jpn J Radiol Techno, 152, pp. 1-8, (1995)

[2]

Schnitt S.J., Connolly J.L., Khettry U., Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy, Cancer, 59, 4, pp. 675-681, (1987)

[3]

Gage I., Schnitt S.J., Nixon A.J., Silver B., Recht A., Troyan S.L., Eberlein T., Love S.M., Gelman R., Harris J.R., Connolly J.L., Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy, Cancer, 78, 9, pp. 1921-1928, (1996)

[4]

Healey E.A., Osteen R.T., Schnitt S.J., Gelman R., Stomper P.C., Connolly J.L., Harris J.R., Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer?, International Journal of Radiation Oncology Biology Physics, 17, 6, pp. 1217-1221, (1989)

[5]

Tsunoda-Shimizu H., Ueno E., Tohno E., Et al., Ultrasonographic evaluation for breast conservative thera- py, Jpn J Breast Cancer, 11, pp. 649-655, (1996)

[6]

Endo T., Ichihara S., Aoyama H., Et al., The indications for breast conserving surgery on mammography, Jpn J Breast Cancer, 11, pp. 643-648, (1996)

[7]

Akashi-Tanaka S., Fukutomi T., Miyakawa K., Uchiyama N., Tsuda H., Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancer, Breast Cancer Research and Treatment, 49, 1, pp. 79-86, (1998)

[8]

Akashi-Tanaka S., Fukutomi T., Miyakawa K., Et al., Diagnostic value of enhanced computed tomography in the detection of the widely spreading intraductal component of breast cancer: Case reports, Breast Cancer, 4, pp. 29-32, (1997)

[9]

Akashi-Tanaka S., Fukutomi T., Miyakawa K., Et al., Clinical use of contrast-enhanced computed tomography for decision making in breast conserving surgery, Breast Cancer, 4, pp. 280-284, (1997)

[10]

Uematsu T., Sano M., Homma K., Shiina M., Kobayashi S., Three-dimensional helical CT of the breast: Accuracy for measuring extent of breast cancer candidates for breast conserving surgery, Breast Cancer Research and Treatment, 65, 3, pp. 249-257, (2001)

← 1 2 3 4 →